Clinical Trials
Positive VIMPAT monotherapy Phase III trial results presented at European Academy of Neurology Congress
Trial further highlights UCB’s longstanding commitment to enhancing value for people living with epilepsy Data submitted to EMA earlier this year to extend the marketing authorization for lacosamide to include monotherapy. In the Europe, lacosamide is currently only...
Clinical Trials
Merck Announces Results From Phase 3 Studies of ZEPATIER™ in Chronic Hepatitis C Patient Populations at The International Liver Congress™
Merck, known as MSD outside of the United States and Canada, today announced the presentation of results from two Phase 3 clinical trials evaluating ZEPATIER™ (elbasvir and grazoprevir) 50mg/100mg tablets in chronic hepatitis C (HCV) patients with inherited blood...
Clinical Trials
First-in-Human Clinical Trial for New Molecular Targeting Drug, Co-Developed with The University of Tokyo and National Cancer Center
The National Cancer Center, The University of Tokyo, and Daiichi Sankyo Company, Limited announced a collaboration to develop a histone methylation enzyme EZH1/2 dual inhibitor (DS-3201), as a new molecular targeting agent for hematologic malignancy, and the commencement of...
Clinical Trials
Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study of defibrotide were published online in BLOOD, the Journal of the American Society of Hematology (ASH). The data demonstrated that defibrotide...
Clinical Trials
clinical trials are critical for determining the safety and efficacy of new medicines and are integral to Roche’s strategy of developing innovative medicines and...
Roche is committed to sharing data from clinical trials and has registered and posted summary reports for trials involving patients on clinicaltrials.gov and on roche-trials.com since 2005. Alongside this posting, we actively seek presentation and publication of our clinical...
Clinical Trials
Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide
Primary Endpoint Met in Study of Postmenopausal Women With Osteoporosis Transitioning From Bisphosphonate Treatment Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced top-line results from the STRUCTURE trial (STudy evaluating effect of RomosozUmab Compared...
Clinical Trials
Immunotherapy Atezolizumab Shrank Tumors in People with a Specific Type of Lung Cancer
Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of atezolizumab’s Breakthrough Therapy Designation in lung cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read